Literature DB >> 24081673

The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms.

Leonardo Vinícius Monteiro de Assis1, Mauro César Isoldi.   

Abstract

The malignant mesothelioma is an aggressive form of cancer with a mean survival rate of less than a year. Moreover, environmental exposure to minerals is an important factor in the development of malignant mesothelioma (MM), especially the mineral asbestos, which has a well-documented role in MM, and more recently, the mineral erionite has been proven to be a strong carcinogenic inducer of MM. In addition, the virus simian virus 40 has been implicated as a co-carcinogenic player in MM. However, the molecular mechanisms involved in the pathogenesis of this cancer are still not fully understood. Indeed, it is known that several genes are altered or mutated in MM, among those are p16(INK4A), p14(ARF), and neurofibromatosis type II. Furthermore, TP53 has been reported to be mutated in the majority of the cancers; however, in MM, it is very uncommon mutations in this gene. Also, the PTEN gene has been shown to play an important role in endometrial cancer and glioblastoma, although the role of PTEN in MM has yet to be established. Taken altogether, this review focuses on the historical aspects, molecular mechanisms, interaction with other genes and proteins, and the role of these genes in MM. Lastly, this review questions the cancer theory of the two hits because the functions of both PTEN and TP53 are not fully explained by this theory.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24081673     DOI: 10.1007/s13277-013-1210-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  117 in total

1.  Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells.

Authors:  Margaret E Ginn-Pease; Charis Eng
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

2.  Mechanistic insights into maintenance of high p53 acetylation by PTEN.

Authors:  Andrew G Li; Landon G Piluso; Xin Cai; Gang Wei; William R Sellers; Xuan Liu
Journal:  Mol Cell       Date:  2006-08       Impact factor: 17.970

Review 3.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

Review 4.  Current development of mTOR inhibitors as anticancer agents.

Authors:  Sandrine Faivre; Guido Kroemer; Eric Raymond
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

5.  Inhibition of the PI3K pathway: hope we can believe in?

Authors:  Michiel S van der Heijden; René Bernards
Journal:  Clin Cancer Res       Date:  2010-04-16       Impact factor: 12.531

6.  Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth.

Authors:  Deborah A Altomare; Huihong You; Guang-Hui Xiao; Maria E Ramos-Nino; Kristine L Skele; Assunta De Rienzo; Suresh C Jhanwar; Brooke T Mossman; Agnes B Kane; Joseph R Testa
Journal:  Oncogene       Date:  2005-09-08       Impact factor: 9.867

Review 7.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles.

Authors:  Paul Déléris; Daniel Bacqueville; Stéphanie Gayral; Laurent Carrez; Jean-Pierre Salles; Bertrand Perret; Monique Breton-Douillon
Journal:  J Biol Chem       Date:  2003-07-07       Impact factor: 5.157

9.  Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.

Authors:  S Venkatachalam; Y P Shi; S N Jones; H Vogel; A Bradley; D Pinkel; L A Donehower
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

10.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

View more
  12 in total

1.  Network of microRNA, transcription factors, target genes and host genes in human mesothelioma.

Authors:  Guanhua Zhang; Zhiwen Xu; Ning Wang
Journal:  Exp Ther Med       Date:  2017-04-04       Impact factor: 2.447

2.  Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Wenjian Yao; Xiuguang Qin; Bo Qi; Jianguo Lu; Ling Guo; Fulei Liu; Shangguo Liu; Baosheng Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Crosstalk between Meg3 and miR-1297 regulates growth of testicular germ cell tumor through PTEN/PI3K/AKT pathway.

Authors:  Nian-Qin Yang; Xiao-Jin Luo; Jian Zhang; Guo-Min Wang; Jian-Ming Guo
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  The development of MM is strongly correlated with exposure to asbestos and erionite, as well as to simian virus 40”.

Authors:  Leonardo de Assis; Mauro César Isoldi
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

5.  MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.

Authors:  Hongyan Wang; Xiaoying Guan; Yongsheng Tu; Shaoqiu Zheng; Jie Long; Shuhua Li; Cuiling Qi; Xiaobin Xie; Huiqiu Zhang; Yajie Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-06-11

6.  The component formula of Salvia miltiorrhiza and Panax ginseng induces apoptosis and inhibits cell invasion and migration through targeting PTEN in lung cancer cells.

Authors:  Lei Bi; Xiaojing Yan; Ye Yang; Lei Qian; Yuan Tian; Jian-Hua Mao; Weiping Chen
Journal:  Oncotarget       Date:  2017-09-28

7.  Cytogenomic characterization of three murine malignant mesothelioma tumor cell lines.

Authors:  Eva Wahlbuhl; Thomas Liehr; Martina Rincic; Shaymaa Azawi
Journal:  Mol Cytogenet       Date:  2020-09-09       Impact factor: 2.009

8.  Pectolinarigenin inhibits non‑small cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway.

Authors:  Fei Xu; Xuan Gao; Huiyun Pan
Journal:  Oncol Rep       Date:  2018-10-02       Impact factor: 3.906

Review 9.  Overview of the biochemical and genetic processes in malignant mesothelioma.

Authors:  Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

10.  Overexpression of micro ribonucleic acid-591 inhibits cell proliferation and invasion of malignant pleural mesothelioma cells.

Authors:  Shizhao Cheng; Yue Xu; Zhenliang Shi; Yongbin Lin; Chuong D Hoang; Xun Zhang
Journal:  Thorac Cancer       Date:  2016-01-31       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.